[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583603":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":29,"locations":36,"responsibleParty":67,"collaborators":69,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":74,"sex":80,"minAge":81,"maxAge":20,"enrollmentInfo":82,"targetDuration":20,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":38,"whyStopped":20,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Group","EXPERIMENTAL","This group includes all adult participants with rare brain tumors who will receive early neuro-cognitive rehabilitation using the RehaCom software.",[13],"Device: RehaCom",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","RehaCom","Participants will receive a personalized neuro-cognitive rehabilitation program using the RehaCom software. Sessions will last approximately 30\u002F40 minutes and will be held twice a week for 8 weeks. The rehabilitation will be aimed at enhancing and\u002For recovering cognitive functions that may have been compromised by the neurosurgical intervention.",[9],null,[22,26],{"name":23,"affiliation":24,"role":25},"Paolo Ferroli, MD","Fondazione IRCCS Istituto Neurologico Carlo Besta","PRINCIPAL_INVESTIGATOR",{"name":27,"affiliation":28,"role":25},"Alessandro Ricci, MD","ASL 1 Abruzzo Avezzano-Sulmona-L'Aquila",[30],{"name":31,"role":32,"phone":33,"phoneExt":34,"email":35},"GIORGIA CAMARDA, Master's degree","CONTACT","+23 02 2394","2949","giorgia.camarda@istituto-besta.it",[37,54],{"facility":24,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Milan","PA","20133","Italy","IT",{"type":45,"coordinates":46},"Point",[47,48],12.59836,42.78235,{"lat":48,"lon":47},[51],{"name":52,"role":32,"phone":53,"phoneExt":34,"email":35},"GIORGIA CAMARDA","02 2394",{"facility":28,"status":55,"city":56,"state":20,"zip":57,"country":42,"countryCode":43,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"NOT_YET_RECRUITING","L’Aquila","67100",{"type":45,"coordinates":59},[60,61],13.39954,42.35055,{"lat":61,"lon":60},[64],{"name":27,"role":32,"phone":65,"phoneExt":34,"email":66},"+ 02 2394","protocollogenerale@pec.asl1abruzzo.it",{"type":68,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[70],{"name":71,"class":6},"ASL 1 Avezzano Sulmona L'Aquila","100583603","simplification-of-care-pathways-for-patients-with-rare-brain-tumors-through-artificial-intelligence-100583603",false,"NCT06878469","SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence","SIMPLIF-AI: SIMPLIFication and Standardization of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence","SIMPLIF-AI","Inclusion Criteria:\n\n* Adults (age ≥18 years)\n* Both sexes\n* Patients with rare brain tumors (incidence \\\u003C6 cases per 100,000 people\u002Fyear)\n* Candidates for craniotomy for rare brain tumors\n* Native Italian speakers for cognitive and psychological evaluation and neuro-cognitive rehabilitation\n\nExclusion Criteria:\n\n* Patients undergoing stereotactic\u002Fframeless biopsy\n* Patients with psychiatric disorders or on psychotropic medications\n* Patients with known cognitive decline (not due to the lesion)\n* Patients admitted on the same day as the surgery\n* Patients with severe impairments referred to rehabilitation centers\n* Patients without a Windows PC or laptop with Internet connection for neuro-cognitive rehabilitation","ALL","18 Years",{"count":83,"type":84},200,"ESTIMATED","INTERVENTIONAL",[87],"NA","This study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under the RARECARE definition of rare tumors. The main objective of the study is to standardize care models and pathways for patients with rare brain tumors, using Artificial Intelligence (AI) and Machine Learning (ML) techniques to identify specific predictors of postoperative outcomes.\n\nThe study includes both retrospective and prospective phases, with the collection of clinical, cognitive, and psychological data at various time points. Patients will undergo an early neuro-cognitive rehabilitation program using the RehaCom software, which will be conducted at home. The goal is to improve the quality of life and care for patients through a multidisciplinary and innovative approach.",[90],"Brain Tumors",[92,93,94,95,96,97,98,99,100,101,102,103,104,105,106],"Rare brain tumors","neurosurgery","outcomes predictions","Machine Learning","Artificial Intelligence","neurocognitive rehabilitation","innovative models","health care pathways","Astrocytic tumors of CNS","Oligodendroglial tumors of CNS","Ependymal tumors of CNS","Neuronal and mixed neuronal-glial tumors","Choroid plexus carcinoma of CNS","Malignant meningiomas","Embryonal tumors of CNS","2026-02-17",{"date":109,"type":110},"2026-02-19","ACTUAL",{"date":112,"type":110},"2025-01-27",{"date":114,"type":84},"2027-02",{"name":5,"class":6},2]